Percutaneous ASD Closure in a Large Australian Series: Short- and Long-Term Outcomes

Walters, D.; Boga, T.; Burstow, Darryl J.; Scalia, G.; Hourigan, Lisa; Aroney, Con

doi:10.1016/j.hlc.2012.05.001

Cited by 9 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…21,[29][30][31][32] Others have also reported significantly higher residual shunt rates with CardioSEAL/STARFlex devices compared with the Amplatzer device, consistent with our results. 24,33 Our center experienced a low long-term mortality rate of 6% overall.…”

Section: Comparison To Current Literaturesupporting

confidence: 90%

Contributors to and impact of residual shunting after device closure of atrial septal defects

Zdradzinski

Elkin

Lee

et al. 2016

American Heart Journal

View full text Add to dashboard Cite

Section: Comparison To Current Literaturesupporting

confidence: 90%

Contributors to and impact of residual shunting after device closure of atrial septal defects

Zdradzinski

Elkin

Lee

et al. 2016

American Heart Journal

View full text Add to dashboard Cite

“…Percutaneous transcatheter device closure of secundum ASDs has become a routine treatment procedure in children . One study of percutaneous device closure of ASDs showed a high success rate of device implantation, and another showed a low incidence of significant complications . Moreover, both studies demonstrated preservation of right ventricular function.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of right ventricular myocardial strains by speckle tracking echocardiography after percutaneous device closure of atrial septal defects in children

Zhou

Tang

et al. 2018

Echocardiography

View full text Add to dashboard Cite

show abstract

“…Several studies have shown outcomes from transcatheter device closure of secundum ASD to be comparable to surgical outcomes in appropriately selected patients [25][26][27]. Presence of any residual shunt at long-term follow-up is reported in approximately 1 % of patients with almost complete resolution of right heart volume overload [28]. Since the era of the pivotal trial of the Amplatzer Septal Occluder, device occlusion of an ASD was noted to have a similarly very low, and in some studies, a slightly lower, mortality when compared with surgical closure [16 •• , 17 • , 29].…”

Section: Resultsmentioning

confidence: 99%

Atrial Septal Defect Device Closure in the Pediatric Population: A Current Review

Crystal

Vincent

2015

Curr Pediatr Rep

View full text Add to dashboard Cite

Atrial septal defects are the most common congenital cardiac defects. The natural history of an uncorrected atrial septal defect causes a shortened life expectancy due to right ventricular volume overload and associated congestive heart failure, atrial arrhythmias, and/ or pulmonary vascular disease. Surgical closure of the atrial septal defect is a procedure with a long-standing history, and the maturing field of percutaneous closure of atrial septal defects by device implantation has established itself to be a feasible, minimally invasive, and safe procedure. Inherent limitations in device designs have resulted in rare, but serious complications, through subsequent changes in the technical aspects of transcatheter atrial septal defect closure that have minimized the number of patients with an adverse event. Recent Food and Drug Administration re-evaluation of the safety of atrial septal defect closure by device has brought to light some of the acute and long-term issues related to device occlusion. This paper summarizes the history of atrial septal defects, surgical and transcatheter device closure, and the most current outcomes of percutaneous atrial septal defect device occlusion in the pediatric population.

show abstract

Percutaneous ASD Closure in a Large Australian Series: Short- and Long-Term Outcomes

Cited by 9 publications

References 12 publications

Contributors to and impact of residual shunting after device closure of atrial septal defects

Contributors to and impact of residual shunting after device closure of atrial septal defects

Evaluation of right ventricular myocardial strains by speckle tracking echocardiography after percutaneous device closure of atrial septal defects in children

Atrial Septal Defect Device Closure in the Pediatric Population: A Current Review

Contact Info

Product

Resources

About